Omniose, a St. Louis-based startup developing better ways to make vaccines that fight bacterial infections, has been acquired by the global pharmaceutical and biotech company AstraZeneca.
The two companies made the announcement Tuesday morning, with Omniose becoming a wholly owned subsidiary of AstraZeneca and a part of its Infectious Disease Unit. The announcement did not disclose financial terms.
Read More at